Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

3
results for

"Tae Seop Lim"

Article category

Keywords

Publication year

"Tae Seop Lim"

Original Article

Hepatic Fibro-inflammation Measured by MRI Iron-Corrected T1 Predicts Extrahepatic Cancer Risk: A UK Biobank Study
Hye Yeon Chon, Seok-Jae Heo, SungA Bae, Tae Seop Lim, Ja Kyung Kim
Received December 3, 2025  Accepted June 8, 2026  Published online June 9, 2026  
DOI: https://doi.org/10.3350/cmh.2025.1372    [Accepted]
Background/Aims
Iron-corrected T1 (cT1) is a magnetic resonance imaging (MRI)-derived biomarker of hepatic fibro-inflammation. This study aimed to investigate whether high cT1 values are associated with an increased risk of extrahepatic malignancy in a large prospective cohort.
Methods
We included 24,003 cancer-free participants from the United Kingdom (UK) Biobank with liver MRI and complete covariate data. Incident extrahepatic malignancy was assessed over a median follow-up of 4.28 years. Multivariable Fine–Gray subdistribution hazard models were used to evaluate the association between cT1 and extrahepatic cancer risk, accounting for competing risks and adjusting for demographic, metabolic, and liver-related factors.
Results
During follow-up, 1,144 participants developed extrahepatic malignancies. In the multivariable analysis, higher cT1 was independently associated with increased extrahepatic cancer risk (hazard ratio [HR], 1.116; 95% confidence interval [CI], 1.033–1.205, per standard deviation increase; P=0.005). Older age (HR, 1.512; 95% CI, 1.402–1.631) and male sex (HR, 1.388; 95% CI, 1.220–1.578) were also significant predictors (P<0.001). The fibrosis-4 score showed a modest positive association (HR, 1.032; 95% CI, 1.004–1.062; P=0.026), whereas MRI-proton density fat fraction demonstrated an inverse association (HR, 0.906; 95% CI, 0.832–0.987; P=0.024). When dichotomized at 771 ms, elevated cT1 was associated with a higher cumulative incidence of extrahepatic malignancy (6.1% vs. 4.6%, P=0.002).
Conclusions
Elevated cT1 is independently associated with an increased risk of future extrahepatic malignancy, suggesting that it may reflect systemic disease processes related to cancer risk. These findings highlight the potential relevance of cT1 beyond liver-specific outcomes; however, further validation is required before clinical implementation.
  • 158 View
  • 13 Download
Editorials

Artificial intelligence, epidemiology, methodology, or others

Is liver biopsy still useful in the era of non-invasive tests?
Tae Seop Lim, Ja Kyung Kim
Clin Mol Hepatol 2020;26(3):302-304.
Published online July 1, 2020
DOI: https://doi.org/10.3350/cmh.2020.0081

Citations

Citations to this article as recorded by  Crossref logo
  • Agreement of VNC and Spectral Photon-Counting CT in the Assessment of Normal to Minimal Hepatic Fat in Comparison with MRI
    David Klemm, Maximilian F. Russe, Marco Reisert, Sebastian Faby, Lukas Rohloff, Tobias Böttler, Michael Schultheiß, Fabian Bamberg, Jakob Weiß, Stephan Rau
    Academic Radiology.2026; 33(5): 1957.     CrossRef
  • Artificial intelligence-assisted rapid on-site evaluation in liver biopsy: a diagnostic accuracy study
    Cheng-Cheng Du, Yu-Xian Chen, Chun-Hai Li, Hong- Meng, Fan-Lei Kong
    Frontiers in Oncology.2026;[Epub]     CrossRef
  • Value of Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) in Assessing Liver Fibrosis in Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Review of its Serum Biomarker Role
    Mohammadjavad Sotoudeheian
    Current Protein & Peptide Science.2025; 26(1): 6.     CrossRef
  • Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank
    Tae Seop Lim, Sujin Kwon, Sung A. Bae, Hye Yeon Chon, Seol A. Jang, Ja Kyung Kim, Chul Sik Kim, Seok Won Park, Kyoung Min Kim
    Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub]     CrossRef
  • Comparison of MRI and CT based deep learning radiomics analyses and their combination for diagnosing intrahepatic cholangiocarcinoma
    Ming Cheng, Hanyue Zhang, Yimin Guo, Peijie Lyu, Jing Yan, Yin Liu, Pan Liang, Zhigang Ren, Jianbo Gao
    Scientific Reports.2025;[Epub]     CrossRef
  • Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non‐Invasive Approach
    Emre Dirican, Tayibe Bal, Yusuf Onlen, Figen Sarigul, Ulku User, Nagehan Didem Sari, Behice Kurtaran, Ebubekir Senates, Alper Gunduz, Esra Zerdali, Hasan Karsen, Ayse Batirel, Ridvan Karaali, Hatice Rahmet Guner, Tansu Yamazhan, Sukran Kose, Nurettin Erbe
    Journal of Clinical Laboratory Analysis.2025;[Epub]     CrossRef
  • Association of CALLY index with NAFLD in U.S. adults from NHANES 2017–2020 assessed by vibration-controlled transient elastography
    Xunge Lin, Xiaozhen Huang, Ziqun Yi, Minran Li, Xujing Liang
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • The Application of Aptamer and Research Progress in Liver Disease
    Cheng Xu, Yong Tan, Li-Ye Zhang, Xiao-Jie Luo, Jiang-Feng Wu, Lan Ma, Fei Deng
    Molecular Biotechnology.2024; 66(5): 1000.     CrossRef
  • Case report: Chronic hepatitis C with anti-HCV positive and serum HCV RNA negative
    Huihui Lu, Wen Deng, Yao Lu, Lu Zhang, Yao Xie, Minghui Li
    Gastroenterology & Endoscopy.2023; 1(2): 120.     CrossRef
  • Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study
    Yoonseok Lee, Seryun Bae, Ji Hoon Kim, Minjung Kwak, So Yeon Jeon, Taehyung Kim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
    Journal of Clinical Medicine.2023; 12(2): 712.     CrossRef
  • Circulating miR-122-5p, miR-92a-3p, and miR-18a-5p as Potential Biomarkers in Human Liver Transplantation Follow-Up
    Cristina Morsiani, Salvatore Collura, Federica Sevini, Erika Ciurca, Valentina Rosa Bertuzzo, Claudio Franceschi, Gian Luca Grazi, Matteo Cescon, Miriam Capri
    International Journal of Molecular Sciences.2023; 24(4): 3457.     CrossRef
  • Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
    Tae Seop Lim, Ho Soo Chun, Soon Sun Kim, Ja Kyung Kim, Minjong Lee, Hyo Jung Cho, Seung Up Kim, Jae Youn Cheong
    Gut and Liver.2023; 17(4): 610.     CrossRef
  • Decreased Bleeding-Related Adverse Events Using Track Embolization with Gelatin Sponge Slurry after Percutaneous Liver Biopsy: A Propensity Score–Matched Study
    Sungho Koh, Hoon Kwon, Lee Hwangbo, Chang Won Kim, Suk Kim, Seung Baek Hong
    Journal of Vascular and Interventional Radiology.2023; 34(12): 2128.     CrossRef
  • Correlation of Inflammatory Bowel Diseases with Liver Involvement Severity in Autoimmune Hepatobiliary Pathology: Cross-Sectional Study
    Olga V. Usoltseva, Andrey N. Surkov, Goar B. Movsisyan, Alexander S. Potapov, Elena A. Kulebina, Кirill A. Kulikov, Vladislav V. Chernikov
    Current Pediatrics.2022; 21(2): 105.     CrossRef
  • Towards Autonomous Robotic Biopsy—Design, Modeling and Control of a Robot for Needle Insertion of a Commercial Full Core Biopsy Instrument
    Seyed MohammadReza Sajadi, Seyed Mojtaba Karbasi, Henrik Brun, Jim Tørresen, Ole Jacob Elle, Kim Mathiassen
    Frontiers in Robotics and AI.2022;[Epub]     CrossRef
  • Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B
    Sung Hwan Yoo, Tae Seop Lim, Hyun Woong Lee, Ja Kyung Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jung Il Lee, Kwan Sik Lee, Seung Up Kim
    Journal of Viral Hepatitis.2021; 28(10): 1362.     CrossRef
  • Realization of improved outcomes following liver resection in hepatocellular carcinoma patients aged 75 years and older
    Jong Man Kim, Jinsoo Rhu, Sang Yun Ha, Gyu-Seong Choi, Choon Hyuck David Kwon, Gaabsoo Kim, Jae-Won Joh
    Annals of Surgical Treatment and Research.2021; 101(5): 257.     CrossRef
  • Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
    Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Gi Soo Youn, Tae Suk Kim, Baek Gyu Jun, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik, Dae Hee Choi, Ki Tae Suk
    Cancers.2020; 12(11): 3347.     CrossRef
  • 10,494 View
  • 149 Download
  • 19 Web of Science
  • Crossref

Viral hepatitis

Use of sofosbuvir in chronic kidney disease: Is it necessary?
Tae Seop Lim, Sang Hoon Ahn
Clin Mol Hepatol 2017;23(4):308-310.
Published online September 26, 2017
DOI: https://doi.org/10.3350/cmh.2017.0109

Citations

Citations to this article as recorded by  Crossref logo
  • Assessment of Renal Function in Egyptian HCV Patients Treated with Combination Therapy of Sofosbuvir and Daclatasvir
    Hala Abd El Maguid, Ahmed Heiba, Enass El Sayed, Hazem El-Hariri, Haythem Tolba, Muhammad Abdel Ghaffar
    Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 82.     CrossRef
  • Sofosbuvir and risk of estimated glomerular filtration rate decline or end‐stage renal disease in patients with renal impairment
    Mark Sulkowski, Laura E. Telep, Massimo Colombo, Francois Durand, K. Rajender Reddy, Eric Lawitz, Marc Bourlière, Nelson Cheinquer, Stacey Scherbakovsky, Liyun Ni, Lindsey Force, Heribert Ramroth, Anuj Gaggar, Anand P. Chokkalingam, Meghan E. Sise
    Alimentary Pharmacology & Therapeutics.2022; 55(9): 1169.     CrossRef
  • Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir
    Ali Nada, Mohamed Abbasy, Aliaa Sabry, Azza Mohamed Abdu Allah, Somaia Shehab-Eldeen, Nada Elnaidany, Hanan Elimam, Kawthar Ibraheem Mohamed Ibraheem, Abdallah Essa
    Canadian Journal of Gastroenterology and Hepatology.2020; 2020: 1.     CrossRef
  • An update on recent developments in the search for hepatitis C virus therapies with pan-genotypic efficacy
    Guglielmo Borgia, Riccardo Scotto, Antonio Riccardo Buonomo
    Expert Opinion on Investigational Drugs.2019; 28(5): 395.     CrossRef
  • Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus Infection
    Riccardo Scotto, Antonio Riccardo Buonomo, Nicola Schiano Moriello, Alberto Enrico Maraolo, Emanuela Zappulo, Biagio Pinchera, Ivan Gentile, Guglielmo Borgia
    Reviews on Recent Clinical Trials.2019; 14(3): 173.     CrossRef
  • Lamivudine: fading into the mists of time
    Jonggi Choi, Young-Suk Lim
    Clinical and Molecular Hepatology.2017; 23(4): 314.     CrossRef
  • 9,200 View
  • 123 Download
  • 4 Web of Science
  • Crossref